nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—NR3C1—Mometasone—systemic scleroderma	0.528	0.759	CbGbCtD
Cyproterone acetate—NR3C1—Prednisone—systemic scleroderma	0.168	0.241	CbGbCtD
Cyproterone acetate—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000245	0.000804	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000244	0.000803	CcSEcCtD
Cyproterone acetate—Anorexia—Mycophenolic acid—systemic scleroderma	0.000243	0.000798	CcSEcCtD
Cyproterone acetate—Tension—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000795	CcSEcCtD
Cyproterone acetate—Dyspnoea—Leflunomide—systemic scleroderma	0.000238	0.000783	CcSEcCtD
Cyproterone acetate—Hypotension—Mycophenolic acid—systemic scleroderma	0.000238	0.000783	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000238	0.000781	CcSEcCtD
Cyproterone acetate—Discomfort—Lisinopril—systemic scleroderma	0.000237	0.000777	CcSEcCtD
Cyproterone acetate—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000237	0.000777	CcSEcCtD
Cyproterone acetate—Dyspepsia—Leflunomide—systemic scleroderma	0.000235	0.000773	CcSEcCtD
Cyproterone acetate—Pancreatitis—Prednisone—systemic scleroderma	0.000235	0.000772	CcSEcCtD
Cyproterone acetate—Vomiting—Mometasone—systemic scleroderma	0.000235	0.000771	CcSEcCtD
Cyproterone acetate—Sweating increased—Prednisone—systemic scleroderma	0.000234	0.000767	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Azathioprine—systemic scleroderma	0.000233	0.000766	CcSEcCtD
Cyproterone acetate—Rash—Mometasone—systemic scleroderma	0.000233	0.000765	CcSEcCtD
Cyproterone acetate—Asthenia—Captopril—systemic scleroderma	0.000233	0.000764	CcSEcCtD
Cyproterone acetate—Dermatitis—Mometasone—systemic scleroderma	0.000233	0.000764	CcSEcCtD
Cyproterone acetate—Decreased appetite—Leflunomide—systemic scleroderma	0.000232	0.000763	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000231	0.00076	CcSEcCtD
Cyproterone acetate—Headache—Mometasone—systemic scleroderma	0.000231	0.00076	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000231	0.000758	CcSEcCtD
Cyproterone acetate—Fatigue—Leflunomide—systemic scleroderma	0.00023	0.000757	CcSEcCtD
Cyproterone acetate—Oedema—Lisinopril—systemic scleroderma	0.00023	0.000754	CcSEcCtD
Cyproterone acetate—Pruritus—Captopril—systemic scleroderma	0.000229	0.000754	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000229	0.000751	CcSEcCtD
Cyproterone acetate—Constipation—Leflunomide—systemic scleroderma	0.000229	0.000751	CcSEcCtD
Cyproterone acetate—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000228	0.000748	CcSEcCtD
Cyproterone acetate—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000227	0.000747	CcSEcCtD
Cyproterone acetate—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000227	0.000744	CcSEcCtD
Cyproterone acetate—Shock—Lisinopril—systemic scleroderma	0.000226	0.000742	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000225	0.000739	CcSEcCtD
Cyproterone acetate—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000224	0.000737	CcSEcCtD
Cyproterone acetate—Tachycardia—Lisinopril—systemic scleroderma	0.000224	0.000736	CcSEcCtD
Cyproterone acetate—Abdominal pain—Azathioprine—systemic scleroderma	0.000224	0.000735	CcSEcCtD
Cyproterone acetate—Body temperature increased—Azathioprine—systemic scleroderma	0.000224	0.000735	CcSEcCtD
Cyproterone acetate—Skin disorder—Lisinopril—systemic scleroderma	0.000223	0.000733	CcSEcCtD
Cyproterone acetate—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000222	0.00073	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000222	0.000729	CcSEcCtD
Cyproterone acetate—Diarrhoea—Captopril—systemic scleroderma	0.000222	0.000729	CcSEcCtD
Cyproterone acetate—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000222	0.000728	CcSEcCtD
Cyproterone acetate—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000221	0.000726	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Prednisone—systemic scleroderma	0.000221	0.000726	CcSEcCtD
Cyproterone acetate—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000221	0.000725	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Leflunomide—systemic scleroderma	0.00022	0.000723	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00022	0.000723	CcSEcCtD
Cyproterone acetate—Fatigue—Mycophenolic acid—systemic scleroderma	0.00022	0.000722	CcSEcCtD
Cyproterone acetate—Mood swings—Methotrexate—systemic scleroderma	0.00022	0.000722	CcSEcCtD
Cyproterone acetate—Nausea—Mometasone—systemic scleroderma	0.000219	0.00072	CcSEcCtD
Cyproterone acetate—Anorexia—Lisinopril—systemic scleroderma	0.000219	0.000719	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000219	0.000718	CcSEcCtD
Cyproterone acetate—Weight increased—Prednisone—systemic scleroderma	0.000218	0.000717	CcSEcCtD
Cyproterone acetate—Constipation—Mycophenolic acid—systemic scleroderma	0.000218	0.000716	CcSEcCtD
Cyproterone acetate—Weight decreased—Prednisone—systemic scleroderma	0.000217	0.000713	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000712	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Prednisone—systemic scleroderma	0.000216	0.000711	CcSEcCtD
Cyproterone acetate—Cough—Mycophenolate mofetil—systemic scleroderma	0.000215	0.000707	CcSEcCtD
Cyproterone acetate—Hypotension—Lisinopril—systemic scleroderma	0.000215	0.000705	CcSEcCtD
Cyproterone acetate—Dizziness—Captopril—systemic scleroderma	0.000214	0.000704	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000214	0.000703	CcSEcCtD
Cyproterone acetate—Urticaria—Leflunomide—systemic scleroderma	0.000212	0.000697	CcSEcCtD
Cyproterone acetate—Abdominal pain—Leflunomide—systemic scleroderma	0.000211	0.000694	CcSEcCtD
Cyproterone acetate—Body temperature increased—Leflunomide—systemic scleroderma	0.000211	0.000694	CcSEcCtD
Cyproterone acetate—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000211	0.000692	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00021	0.00069	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Prednisone—systemic scleroderma	0.00021	0.000689	CcSEcCtD
Cyproterone acetate—Breast disorder—Methotrexate—systemic scleroderma	0.00021	0.000688	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Azathioprine—systemic scleroderma	0.000209	0.000685	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000209	0.000685	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000208	0.000685	CcSEcCtD
Cyproterone acetate—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000207	0.000681	CcSEcCtD
Cyproterone acetate—Vomiting—Captopril—systemic scleroderma	0.000206	0.000677	CcSEcCtD
Cyproterone acetate—Dyspnoea—Lisinopril—systemic scleroderma	0.000205	0.000673	CcSEcCtD
Cyproterone acetate—Rash—Captopril—systemic scleroderma	0.000205	0.000672	CcSEcCtD
Cyproterone acetate—Dermatitis—Captopril—systemic scleroderma	0.000204	0.000671	CcSEcCtD
Cyproterone acetate—Headache—Captopril—systemic scleroderma	0.000203	0.000667	CcSEcCtD
Cyproterone acetate—Dyspepsia—Lisinopril—systemic scleroderma	0.000202	0.000664	CcSEcCtD
Cyproterone acetate—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000202	0.000662	CcSEcCtD
Cyproterone acetate—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000202	0.000662	CcSEcCtD
Cyproterone acetate—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000201	0.000661	CcSEcCtD
Cyproterone acetate—Asthma—Methotrexate—systemic scleroderma	0.0002	0.000658	CcSEcCtD
Cyproterone acetate—Decreased appetite—Lisinopril—systemic scleroderma	0.0002	0.000656	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000198	0.000651	CcSEcCtD
Cyproterone acetate—Fatigue—Lisinopril—systemic scleroderma	0.000198	0.00065	CcSEcCtD
Cyproterone acetate—Shock—Mycophenolate mofetil—systemic scleroderma	0.000198	0.00065	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000197	0.000648	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000197	0.000647	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Leflunomide—systemic scleroderma	0.000197	0.000647	CcSEcCtD
Cyproterone acetate—Pancreatitis—Methotrexate—systemic scleroderma	0.000197	0.000646	CcSEcCtD
Cyproterone acetate—Constipation—Lisinopril—systemic scleroderma	0.000196	0.000645	CcSEcCtD
Cyproterone acetate—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000196	0.000645	CcSEcCtD
Cyproterone acetate—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000642	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000639	CcSEcCtD
Cyproterone acetate—Diarrhoea—Azathioprine—systemic scleroderma	0.000194	0.000636	CcSEcCtD
Cyproterone acetate—Haemoglobin—Prednisone—systemic scleroderma	0.000193	0.000634	CcSEcCtD
Cyproterone acetate—Nausea—Captopril—systemic scleroderma	0.000193	0.000633	CcSEcCtD
Cyproterone acetate—Haemorrhage—Prednisone—systemic scleroderma	0.000192	0.000631	CcSEcCtD
Cyproterone acetate—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000192	0.00063	CcSEcCtD
Cyproterone acetate—Asthenia—Leflunomide—systemic scleroderma	0.000192	0.00063	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Lisinopril—systemic scleroderma	0.000189	0.000622	CcSEcCtD
Cyproterone acetate—Pruritus—Leflunomide—systemic scleroderma	0.000189	0.000621	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Prednisone—systemic scleroderma	0.000189	0.00062	CcSEcCtD
Cyproterone acetate—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000188	0.000618	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000188	0.000617	CcSEcCtD
Cyproterone acetate—Dizziness—Azathioprine—systemic scleroderma	0.000187	0.000615	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000185	0.000606	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000183	0.000601	CcSEcCtD
Cyproterone acetate—Asthenia—Mycophenolic acid—systemic scleroderma	0.000183	0.000601	CcSEcCtD
Cyproterone acetate—Diarrhoea—Leflunomide—systemic scleroderma	0.000183	0.000601	CcSEcCtD
Cyproterone acetate—Urticaria—Lisinopril—systemic scleroderma	0.000182	0.000599	CcSEcCtD
Cyproterone acetate—Abdominal pain—Lisinopril—systemic scleroderma	0.000182	0.000596	CcSEcCtD
Cyproterone acetate—Body temperature increased—Lisinopril—systemic scleroderma	0.000182	0.000596	CcSEcCtD
Cyproterone acetate—Pruritus—Mycophenolic acid—systemic scleroderma	0.00018	0.000593	CcSEcCtD
Cyproterone acetate—Vomiting—Azathioprine—systemic scleroderma	0.00018	0.000591	CcSEcCtD
Cyproterone acetate—Eye disorder—Prednisone—systemic scleroderma	0.000179	0.000589	CcSEcCtD
Cyproterone acetate—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000179	0.000589	CcSEcCtD
Cyproterone acetate—Rash—Azathioprine—systemic scleroderma	0.000178	0.000586	CcSEcCtD
Cyproterone acetate—Dermatitis—Azathioprine—systemic scleroderma	0.000178	0.000586	CcSEcCtD
Cyproterone acetate—Headache—Azathioprine—systemic scleroderma	0.000177	0.000582	CcSEcCtD
Cyproterone acetate—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000177	0.000582	CcSEcCtD
Cyproterone acetate—Dizziness—Leflunomide—systemic scleroderma	0.000177	0.000581	CcSEcCtD
Cyproterone acetate—Renal failure—Methotrexate—systemic scleroderma	0.000176	0.000577	CcSEcCtD
Cyproterone acetate—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000175	0.000575	CcSEcCtD
Cyproterone acetate—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000174	0.000573	CcSEcCtD
Cyproterone acetate—Angiopathy—Prednisone—systemic scleroderma	0.000174	0.000572	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000571	CcSEcCtD
Cyproterone acetate—Immune system disorder—Prednisone—systemic scleroderma	0.000173	0.00057	CcSEcCtD
Cyproterone acetate—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000565	CcSEcCtD
Cyproterone acetate—Sweating—Methotrexate—systemic scleroderma	0.000171	0.000563	CcSEcCtD
Cyproterone acetate—Haematuria—Methotrexate—systemic scleroderma	0.00017	0.00056	CcSEcCtD
Cyproterone acetate—Vomiting—Leflunomide—systemic scleroderma	0.00017	0.000558	CcSEcCtD
Cyproterone acetate—Alopecia—Prednisone—systemic scleroderma	0.00017	0.000557	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Lisinopril—systemic scleroderma	0.000169	0.000556	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000169	0.000555	CcSEcCtD
Cyproterone acetate—Dizziness—Mycophenolic acid—systemic scleroderma	0.000169	0.000554	CcSEcCtD
Cyproterone acetate—Rash—Leflunomide—systemic scleroderma	0.000169	0.000554	CcSEcCtD
Cyproterone acetate—Dermatitis—Leflunomide—systemic scleroderma	0.000168	0.000553	CcSEcCtD
Cyproterone acetate—Mental disorder—Prednisone—systemic scleroderma	0.000168	0.000552	CcSEcCtD
Cyproterone acetate—Nausea—Azathioprine—systemic scleroderma	0.000168	0.000552	CcSEcCtD
Cyproterone acetate—Headache—Leflunomide—systemic scleroderma	0.000167	0.00055	CcSEcCtD
Cyproterone acetate—Malnutrition—Prednisone—systemic scleroderma	0.000167	0.000549	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000166	0.000545	CcSEcCtD
Cyproterone acetate—Asthenia—Lisinopril—systemic scleroderma	0.000165	0.000541	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000165	0.00054	CcSEcCtD
Cyproterone acetate—Pruritus—Lisinopril—systemic scleroderma	0.000163	0.000534	CcSEcCtD
Cyproterone acetate—Vomiting—Mycophenolic acid—systemic scleroderma	0.000162	0.000532	CcSEcCtD
Cyproterone acetate—Haemoglobin—Methotrexate—systemic scleroderma	0.000161	0.00053	CcSEcCtD
Cyproterone acetate—Rash—Mycophenolic acid—systemic scleroderma	0.000161	0.000528	CcSEcCtD
Cyproterone acetate—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000161	0.000528	CcSEcCtD
Cyproterone acetate—Haemorrhage—Methotrexate—systemic scleroderma	0.00016	0.000527	CcSEcCtD
Cyproterone acetate—Hepatitis—Methotrexate—systemic scleroderma	0.00016	0.000527	CcSEcCtD
Cyproterone acetate—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000525	CcSEcCtD
Cyproterone acetate—Headache—Mycophenolic acid—systemic scleroderma	0.00016	0.000525	CcSEcCtD
Cyproterone acetate—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000522	CcSEcCtD
Cyproterone acetate—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000522	CcSEcCtD
Cyproterone acetate—Nausea—Leflunomide—systemic scleroderma	0.000159	0.000521	CcSEcCtD
Cyproterone acetate—Diarrhoea—Lisinopril—systemic scleroderma	0.000157	0.000516	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Prednisone—systemic scleroderma	0.000155	0.000509	CcSEcCtD
Cyproterone acetate—Visual impairment—Methotrexate—systemic scleroderma	0.000155	0.000508	CcSEcCtD
Cyproterone acetate—Anaemia—Prednisone—systemic scleroderma	0.000154	0.000507	CcSEcCtD
Cyproterone acetate—Agitation—Prednisone—systemic scleroderma	0.000154	0.000504	CcSEcCtD
Cyproterone acetate—Dizziness—Lisinopril—systemic scleroderma	0.000152	0.000499	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Methotrexate—systemic scleroderma	0.000152	0.000498	CcSEcCtD
Cyproterone acetate—Nausea—Mycophenolic acid—systemic scleroderma	0.000151	0.000497	CcSEcCtD
Cyproterone acetate—Malaise—Prednisone—systemic scleroderma	0.000151	0.000495	CcSEcCtD
Cyproterone acetate—Eye disorder—Methotrexate—systemic scleroderma	0.00015	0.000493	CcSEcCtD
Cyproterone acetate—Syncope—Prednisone—systemic scleroderma	0.00015	0.000492	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000487	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Prednisone—systemic scleroderma	0.000147	0.000482	CcSEcCtD
Cyproterone acetate—Vomiting—Lisinopril—systemic scleroderma	0.000146	0.00048	CcSEcCtD
Cyproterone acetate—Angiopathy—Methotrexate—systemic scleroderma	0.000146	0.000478	CcSEcCtD
Cyproterone acetate—Immune system disorder—Methotrexate—systemic scleroderma	0.000145	0.000476	CcSEcCtD
Cyproterone acetate—Rash—Lisinopril—systemic scleroderma	0.000145	0.000476	CcSEcCtD
Cyproterone acetate—Dermatitis—Lisinopril—systemic scleroderma	0.000145	0.000475	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000145	0.000475	CcSEcCtD
Cyproterone acetate—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000474	CcSEcCtD
Cyproterone acetate—Chills—Methotrexate—systemic scleroderma	0.000144	0.000473	CcSEcCtD
Cyproterone acetate—Headache—Lisinopril—systemic scleroderma	0.000144	0.000473	CcSEcCtD
Cyproterone acetate—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000468	CcSEcCtD
Cyproterone acetate—Alopecia—Methotrexate—systemic scleroderma	0.000142	0.000466	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000141	0.000464	CcSEcCtD
Cyproterone acetate—Discomfort—Prednisone—systemic scleroderma	0.000141	0.000462	CcSEcCtD
Cyproterone acetate—Mental disorder—Methotrexate—systemic scleroderma	0.000141	0.000462	CcSEcCtD
Cyproterone acetate—Malnutrition—Methotrexate—systemic scleroderma	0.00014	0.000459	CcSEcCtD
Cyproterone acetate—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000138	0.000452	CcSEcCtD
Cyproterone acetate—Nausea—Lisinopril—systemic scleroderma	0.000136	0.000448	CcSEcCtD
Cyproterone acetate—Oedema—Prednisone—systemic scleroderma	0.000136	0.000448	CcSEcCtD
Cyproterone acetate—Shock—Prednisone—systemic scleroderma	0.000134	0.000441	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Prednisone—systemic scleroderma	0.000134	0.000439	CcSEcCtD
Cyproterone acetate—Tachycardia—Prednisone—systemic scleroderma	0.000133	0.000437	CcSEcCtD
Cyproterone acetate—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000437	CcSEcCtD
Cyproterone acetate—Skin disorder—Prednisone—systemic scleroderma	0.000133	0.000435	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Prednisone—systemic scleroderma	0.000132	0.000433	CcSEcCtD
Cyproterone acetate—Anorexia—Prednisone—systemic scleroderma	0.00013	0.000427	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Methotrexate—systemic scleroderma	0.00013	0.000426	CcSEcCtD
Cyproterone acetate—Anaemia—Methotrexate—systemic scleroderma	0.000129	0.000424	CcSEcCtD
Cyproterone acetate—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000128	0.00042	CcSEcCtD
Cyproterone acetate—Rash—Mycophenolate mofetil—systemic scleroderma	0.000127	0.000417	CcSEcCtD
Cyproterone acetate—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000127	0.000416	CcSEcCtD
Cyproterone acetate—Headache—Mycophenolate mofetil—systemic scleroderma	0.000126	0.000414	CcSEcCtD
Cyproterone acetate—Malaise—Methotrexate—systemic scleroderma	0.000126	0.000414	CcSEcCtD
Cyproterone acetate—Leukopenia—Methotrexate—systemic scleroderma	0.000125	0.000411	CcSEcCtD
Cyproterone acetate—Cough—Methotrexate—systemic scleroderma	0.000122	0.0004	CcSEcCtD
Cyproterone acetate—Dyspepsia—Prednisone—systemic scleroderma	0.00012	0.000394	CcSEcCtD
Cyproterone acetate—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00012	0.000393	CcSEcCtD
Cyproterone acetate—Decreased appetite—Prednisone—systemic scleroderma	0.000119	0.000389	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000118	0.000388	CcSEcCtD
Cyproterone acetate—Fatigue—Prednisone—systemic scleroderma	0.000118	0.000386	CcSEcCtD
Cyproterone acetate—Discomfort—Methotrexate—systemic scleroderma	0.000118	0.000386	CcSEcCtD
Cyproterone acetate—Constipation—Prednisone—systemic scleroderma	0.000117	0.000383	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Prednisone—systemic scleroderma	0.000112	0.000369	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Methotrexate—systemic scleroderma	0.000112	0.000367	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000112	0.000367	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000112	0.000366	CcSEcCtD
Cyproterone acetate—Skin disorder—Methotrexate—systemic scleroderma	0.000111	0.000364	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00011	0.000362	CcSEcCtD
Cyproterone acetate—Anorexia—Methotrexate—systemic scleroderma	0.000109	0.000357	CcSEcCtD
Cyproterone acetate—Urticaria—Prednisone—systemic scleroderma	0.000108	0.000356	CcSEcCtD
Cyproterone acetate—Body temperature increased—Prednisone—systemic scleroderma	0.000108	0.000354	CcSEcCtD
Cyproterone acetate—Abdominal pain—Prednisone—systemic scleroderma	0.000108	0.000354	CcSEcCtD
Cyproterone acetate—Hypotension—Methotrexate—systemic scleroderma	0.000107	0.00035	CcSEcCtD
Cyproterone acetate—Dyspnoea—Methotrexate—systemic scleroderma	0.000102	0.000334	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Prednisone—systemic scleroderma	0.000101	0.00033	CcSEcCtD
Cyproterone acetate—Dyspepsia—Methotrexate—systemic scleroderma	0.0001	0.00033	CcSEcCtD
Cyproterone acetate—Decreased appetite—Methotrexate—systemic scleroderma	9.91e-05	0.000325	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Methotrexate—systemic scleroderma	9.84e-05	0.000323	CcSEcCtD
Cyproterone acetate—Fatigue—Methotrexate—systemic scleroderma	9.83e-05	0.000323	CcSEcCtD
Cyproterone acetate—Asthenia—Prednisone—systemic scleroderma	9.79e-05	0.000321	CcSEcCtD
Cyproterone acetate—Pruritus—Prednisone—systemic scleroderma	9.65e-05	0.000317	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Methotrexate—systemic scleroderma	9.39e-05	0.000309	CcSEcCtD
Cyproterone acetate—Diarrhoea—Prednisone—systemic scleroderma	9.33e-05	0.000307	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Methotrexate—systemic scleroderma	9.32e-05	0.000306	CcSEcCtD
Cyproterone acetate—Urticaria—Methotrexate—systemic scleroderma	9.06e-05	0.000297	CcSEcCtD
Cyproterone acetate—Dizziness—Prednisone—systemic scleroderma	9.02e-05	0.000296	CcSEcCtD
Cyproterone acetate—Body temperature increased—Methotrexate—systemic scleroderma	9.01e-05	0.000296	CcSEcCtD
Cyproterone acetate—Abdominal pain—Methotrexate—systemic scleroderma	9.01e-05	0.000296	CcSEcCtD
Cyproterone acetate—Vomiting—Prednisone—systemic scleroderma	8.67e-05	0.000285	CcSEcCtD
Cyproterone acetate—Rash—Prednisone—systemic scleroderma	8.6e-05	0.000282	CcSEcCtD
Cyproterone acetate—Dermatitis—Prednisone—systemic scleroderma	8.59e-05	0.000282	CcSEcCtD
Cyproterone acetate—Headache—Prednisone—systemic scleroderma	8.55e-05	0.000281	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Methotrexate—systemic scleroderma	8.4e-05	0.000276	CcSEcCtD
Cyproterone acetate—Asthenia—Methotrexate—systemic scleroderma	8.18e-05	0.000269	CcSEcCtD
Cyproterone acetate—Nausea—Prednisone—systemic scleroderma	8.1e-05	0.000266	CcSEcCtD
Cyproterone acetate—Pruritus—Methotrexate—systemic scleroderma	8.07e-05	0.000265	CcSEcCtD
Cyproterone acetate—Diarrhoea—Methotrexate—systemic scleroderma	7.8e-05	0.000256	CcSEcCtD
Cyproterone acetate—Dizziness—Methotrexate—systemic scleroderma	7.54e-05	0.000248	CcSEcCtD
Cyproterone acetate—Vomiting—Methotrexate—systemic scleroderma	7.25e-05	0.000238	CcSEcCtD
Cyproterone acetate—Rash—Methotrexate—systemic scleroderma	7.19e-05	0.000236	CcSEcCtD
Cyproterone acetate—Dermatitis—Methotrexate—systemic scleroderma	7.18e-05	0.000236	CcSEcCtD
Cyproterone acetate—Headache—Methotrexate—systemic scleroderma	7.14e-05	0.000235	CcSEcCtD
Cyproterone acetate—Nausea—Methotrexate—systemic scleroderma	6.77e-05	0.000222	CcSEcCtD
